BJ
AVEO

BlackRock Japan’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

BlackRock Japan’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-6,224
Closed -$156K – 1422
2013
Q2 		$156K Buy
+6,224
New +$266K ﹤0.01% 910

Other funds holding AVEO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock Japan's AVEO Position: Q3 2013 in Review

BlackRock Japan sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2013, closing a stake of 6,224 shares — an estimated $156K sold.

BlackRock Japan first reported a position in AVEO in Q2 2013 and held it in 1 quarter. The position peaked at $156K in Q2 2013. 81 funds tracked by Wall St. Rank hold AVEO as of Q3 2013.

  • BlackRock Japan reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2013 after selling out during the quarter.
  • BlackRock Japan sold 6,224 AVEO Pharmaceuticals, Inc. shares in Q3 2013, an estimated $156K.
  • BlackRock Japan first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 1 quarter.
  • BlackRock Japan's AVEO Pharmaceuticals, Inc. position peaked at $156K in Q2 2013.
  • 81 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2013.

Based on BlackRock Japan's 13F filing for Q3 2013, filed 12 Nov 2013.